15% CAGR growth by 2023 in Solid Tumor Therapeutics Market | Major Vendors - ABBOTT LABORATORIES, INC., AMGEN, INC., ASTRAZENECA PLC, BAXTER INTERNATIONAL, INC., BIOGEN, INC., BOEHRINGER INGELHEIM GMBH, BRISTOL-MYERS SQUIBB COMPANY, amongst others.

United States Leads the Market in North America

The United States solid tumor therapeutics market held the largest market share in 2017 in the North American region due to the presence of high-quality healthcare system and modern medical technology in the country. Additionally, the growing awareness about cancer among the public is likely to contribute towards the growth of the solid tumor therapeutics market.

Detailed Sample Copy of Updated Analysis @ https://marketprognosis.com/sample-request/16874
Note: “If this link doesn’t work in Internet Explorer, kindly try pasting it in other browsers.”

Solid tumor therapeutics is pharmaceuticals that specifically treat various cancers, such as breast cancer, lung cancer, colorectal cancer, prostate cancer, cervical cancer, and others. This increasing incidence of cancer is driving the solid tumor therapeutics market. The other factors, such as the increase in demand for POC testing, new product approvals in ovarian, pancreatic and prostate cancers, and the increase in molecular testing are driving the solid tumor therapeutics market. The pharmaceutical company, Novartis, has seen a decline in their income due to the competition for their generic drug

Request Discount on this report @ https://marketprognosis.com/discount-request/16874
Note: “If this link doesn’t work in Internet Explorer, kindly try pasting it in other browsers.”

Market Segments:
Solid tumor therapeutics market is segmented by:
1. Type of Cancer: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer, Others
2. Drugs: Carboplatin, Cisplatin, Gemcitabine, Paclitaxel, Doxorubicin, Bevacizumab (Avastin), Erlotinib (Tarceva), Sunitinib (Sutent), Everolimusa (Afinitor), Docetaxel (Taxotere), Abiraterone Acetate (Zytiga), Cabazitaxel (Jevtana), Others
3. Geography: North America, South America, Europe, Asia Pacific, Middle East & Africa

Key Developments in the Market
• August 2017: Bristol-Myers Squibb acquired IFM Therapeutics to strengthen its oncology segment.
• October 2017: Abbott completed the acquisition of Alere.

Enquiry before Buying @ https://marketprognosis.com/enquiry/16874
Note: “If this link doesn’t work in Internet Explorer, kindly try pasting it in other browsers.”

About Market Prognosis
We at Market Prognosis believe in giving a crystal clear view of market dynamics for achieving success in today's complex and competitive marketplace through our quantitative & qualitative research methods.
We help our clients identify the best market insights and analysis required for their business thus enabling them to take strategic and intelligent decision.
We believe in delivering actionable insights for your business growth and success.

Contact us:
ProgMark Pvt Ltd,
Thane - 421501
India.
Contact No: +1 973 241 5193
Email: sales@marketprognosis.com

This release was published on openPR.